SCHEMBL13699684

SCHEMBL13699684

Cc1cc2oc(C(N)=O)c(N)c2cc1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 15/20 0.51
ALDH1A1 P00352 8/20 0.51
HSD17B10 Q99714 8/20 0.51
HPGD P15428 7/20 0.51
SMN1; SMN2 Q16637 8/20 0.38
TP53 P04637 2/20 0.38
HTT P42858 1/20 0.38
MAPT P10636 7/20 0.36
NPC1 O15118 7/20 0.36
RAB9A P51151 7/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
LMNA P02545 1/20 0.36
AHR P35869 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
GPR35 Q9HC97 1/20 0.34
ADORA2A P29274 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13699680 0.87 KDM4E (0.57) KDM4EALDH1A1HSD17B10HPGDSMN1; SMN2
SCHEMBL1853246 0.74 KDM4E (0.67) KDM4EALDH1A1HSD17B10HPGDSMN1; SMN2
SCHEMBL13699685 0.74 KDM4E (0.54) KDM4EALDH1A1HSD17B10HPGDSMN1; SMN2
SCHEMBL13699669 0.74 KDM4E (0.54) KDM4EALDH1A1HSD17B10HPGDSMN1; SMN2
SCHEMBL1852815 0.74 KDM4E (0.67) KDM4EALDH1A1HSD17B10HPGDSMN1; SMN2
SCHEMBL13699847 0.74 KDM4E (0.53) KDM4EALDH1A1HSD17B10HPGDSMN1; SMN2
SCHEMBL13699865 0.73 MAPT (0.65) KDM4EALDH1A1HSD17B10HPGDTP53
SCHEMBL13699870 0.70 MAPT (0.53) KDM4EALDH1A1HSD17B10HPGDSMN1; SMN2
SCHEMBL20535965 0.70 KDM4E (0.60) KDM4EALDH1A1HSD17B10HPGDSMN1; SMN2
SCHEMBL12660566 0.69 KDM4E (0.69) KDM4EALDH1A1HSD17B10HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F KDM4E 4227/4885ALDH1A1 559/4885HSD17B10 1250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.